Summary
Sulphasalazine was administered to 48 patients with reactive synovitis (RS) and ankylosing spondylitis (AS) with peripheral arthritis, resistent to nonsteroidal antiinflammatory drugs. Thirty-seven patients underwent an ileocolonoscopy and in 33 patients signs of chronic or active inflammation of the ileum and/or ileocecal valve were found. Forty-two patients improved after 3 to 12 months of treatment; 50 per cent of them went into remission. In most of the patients improvement failed to occur in the first 2 months of treatment. There was no recurrent disease activity in patients responding to the treatment. Adverse reactions were rare and did not necessitate interruption of treatment. The beneficial effect of sulphasalazine in the treatment of RS and AS with peripheral arthritis needs to be confirmed in double-blind controlled studies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Keat, A. Reiter's syndrome and reactive arthritis in perspective. New Engl J Med, 1983, 309, 1606.
Mielants, H., Veys, E.M. Inflammation of the ileum in patients with B27-positive reactive arthritis. Lancet, I, 1984, 8371, 288.
Mielants, H., Veys, E.M. Reiter's syndrome and reactive arthritis. New Engl J Med 1984, 310, 1538.
Mielants, H., Veys, E.M., Cuvelier, C. et al. HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis. J Rheumatol 1985, 12, 294–298.
Anthonisen, P., Barany, F., Fokenborg, O. et al. The clinical effect of salazosulphapyridine in Crohn's disease. A controlled double-blind study. Scand J Gastroenterol 1974, 9, 549–554.
Van Hees, P.A.J., Van Lier, H.J.J., Van Elteren, P.G. et al. Effect of sulphasalazine in patients with active Crohn's disease: a controlled doubleblind study. Gut 1981, 22, 404–409.
Mielants, H., Veys, E.M. HLA-B27 related arthritis and bowel inflammation. Part 1. Sulfasalazine (Salazopyrin) in HLA-B27 related reactive arthritis. J Rheumatol 1985, 12, 287–293.
Kellgren, Jr., Jeffrey, M.R., Ball, J., eds. The Epidemiology of Chronic Rheumatism, Vol. 1. Oxford-Blackwell, 1963, 326.
McConkey, B., Amos, S., Durham, S. et al. Sulphasalazine in rheumatoid arthritis. Bull Med J 1980, 442–444.
Bax, D.E., Amos, R.S. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate. Ann Rheum Dis 1985, 44, 194–198.
Pullar, T., Capell, H.A. Sulphasalazine: a new antirheumatic drug. Br J Rheumatol 1984, 23, 26–34.
Bird, H.A., Dixon, J.S., Picup, M.E. et al. A biochemical assessment of sulphasalazine in rheumatoid arthritis. J Rheumatol 1982, 9, 36–45.
Pullar, T., Hunter, J.A., Capell, H.A. Sulphasalazine in rheumatoid arthritis. Lancet 1, 1985, 1167.
Pullar, T., Hunter, J.A., Capell, H.A. Toxicity of sulphasalazine in patients with rheumatoid arthritis. Br J Rheumatol 1985, 24, 214.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mielants, H., Veys, E.M. & Joos, R. Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis. Clin Rheumatol 5, 80–83 (1986). https://doi.org/10.1007/BF02030973
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02030973